Impact of a protocol advocating dexmedetomidine over propofol sedation after robotic-assisted direct coronary artery bypass surgery on duration of mechanical ventilation and patient safety.

@article{Torbic2013ImpactOA,
  title={Impact of a protocol advocating dexmedetomidine over propofol sedation after robotic-assisted direct coronary artery bypass surgery on duration of mechanical ventilation and patient safety.},
  author={Heather Torbic and Stella Papadopoulos and Justin Manjourides and John W. Devlin},
  journal={The Annals of pharmacotherapy},
  year={2013},
  volume={47 4},
  pages={
          441-6
        }
}
BACKGROUND Controversy remains whether propofol or dexmedetomidine is the preferred sedative following cardiac surgery. Dexmedetomidine may offer advantages over propofol among patients undergoing robotic-assisted, minimally invasive, direct coronary artery bypass (MIDCAB) surgery given the rapidity with which this population is usually extubated after surgery. OBJECTIVE To measure the impact of a surgery protocol advocating use of dexmedetomidine rather than propofol after MIDCAB surgery on… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation

  • SM Hoy, GM Keating
  • Drugs ;30:1481-501
  • 2011

Similar Papers

Loading similar papers…